Patient Dosing Resumes in Alzheimer’s Clinical Trial
21 1월 2022 - 3:48AM
AllPennyStocks.com
Treatments for Alzheimer’s continue to be lacking in the
clinical community. A drug repurposing by the pharmaceutical
company has the potential to be an effective treatment for mild
to...
To read the full story on AllPennyStocks.com, click
here.
Intelgenx Technologies (TSX:IGX)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Intelgenx Technologies (TSX:IGX)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024